13 - Systemic Sclerosis Flashcards
1
Q
What is systemic sclerosis/scleroderma (SSc)?
A
Autoimmune or connective tissue disease characterized by thickening of the skin caused by accumulation of collagen, and by injuries to the smallest arteries
2
Q
What is the prevalence of SSc in the US?
A
276 per million
3
Q
What is the 10-year mortality rate of SSc?
A
23-45%
4
Q
True or false: There is no demonstrated disease-modifying therapy for SSc
A
True
5
Q
What are the subclassifications of SSc?
A
- Limited cutaneous SSc (lcSSc)
- Diffuse cutaneous SSc (dcSSc)
6
Q
What is the pathophysiology of SSc?
A
- Must incorporate the 3 cardinal features of the disease:
- (1) vasculopathy (intimal hyperplasia, vessel obliteration, thrombosis)
- (2) cellular and humoral autoimmunity (TGF-B, Th2 cytokines, PDGF, CTGF, chemokines)
- (3) progressive visceral and vascular fibrosis in multiple organs (loss normal architecture, impaired function, organ failure)
- Autoimmunity and altered vascular reactivity may be the earliest manifestations
- Complex interplay between these processes is thought to initiate and then amplify the fibrotic process
7
Q
Anti-PM-Scl AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- PM-Scl 100 7 PM-Scl 70 components of human exosome
- 5%
- Overlap w/ myositis
8
Q
Anti-Th/To AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- Ribonuclease mitochondrial RNA processing & ribonuclease P complexes
- 5%
- lcSSc; ILD
9
Q
Anti-U3RNP AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- 34-kDa basic protein fibrillarin
- 5%
- pHTN; skeletal muscle involvement; AfAm predominance
10
Q
Anti-RNA polymerase III AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- RNA polymerase III
- 10%
- dcSSc; rapidly progressive skin dz; renal crisis
11
Q
Anti-Scl-70 AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- Topoisomerase I
- 20%
- dcSSc; ILD
12
Q
Anti-centromere AAb
- Main autoantigen target
- Frequency
- Clincal associations
A
- Centromere proteins
- 30%
- lcSSc; digital ischemia
13
Q
What are the clinical manifestations of SSc?
A
- Raynaud’s phenomenon
- Digital ulcerations
- Calcinosis
- GI manifestations
- Tendon friction rubs
- Fibrosis of skin
- Renal crisis
- ILD
- pHTN
14
Q
What is Raynaud’s phenomenon?
A
- Triphasic color change upon cold exposure
- White –> blue –>